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Abstract
Purpose Painful pseudarthrosis is one of the most important
indications for (revision) surgery after spinal fusion proce-
dures. If pseudarthrosis is the source of recurrent pain it may
require revision surgery. It is therefore of great clinical impor-
tance to ascertain if it is the source of such pain. The correla-
tion between findings on conventional imaging (plain radiog-
raphy and CT) and clinical well-being has been shown to be
moderate. The goal of this study was to determine the possible
role of 18F-fluoride PET in patients after lumbar spinal
interbody fusion by investigating the relationship between
PET/CT findings and clinical function and pain.
Methods A cohort of 36 patients was retrospectively included
in the study after 18F-fluoride PET/CT for either persistent or
recurrent low back pain (18 patients) or during routine post-
operative investigation (18 patients) between 9 and 76months
and 11 and 14 months after posterior lumbar interbody fusion,
respectively. Sixty minutes after intravenous injection of
156 – 263 MBq (mean 199 MBq, median 196 MBq) 18F-
fluoride, PETand CT images were acquired using an integrat-
ed PET/CT scanner, followed by a diagnostic CT scan. Two
observers independently scored the images. The number of
bony bridges between vertebrae was scored on the CT images
to quantify interbody fusion (0, 1 or 2). Vertebral endplate and
intervertebral disc space uptake were evaluated visually as
well as semiquantitatively following 18F-fluoride PET.
Findings on PET and CT were correlated with clinical
wellbeing as measured by validated questionnaires
concerning general daily functioning (Oswestry Disability In-
dex), pain (visual analogue scale) and general health status
(EuroQol). Patients were divided into three categories based
on these questionnaire scores.
Results No correlation was found between symptom severity
and fusion status. However, 18F-fluoride activity in the verte-
bral endplates was significantly higher in patients in the lowest
Oswestry Disability Index category (i.e. with the worst clini-
cal performance) than in patients in higher categories (p=0.01
between categories 1 and 2 and 1 and 3). The visual analogue
scale and EuroQol results were similar although less pro-
nounced, with only SUVmax between category 1 and 2 being
significantly different (p=0.04).
Conclusion We hypothesize that 18F-fluoride PET/CTmay be
able to provide support for the diagnosis of painful
pseudarthrosis and could serve as a tool to discriminate be-
tween symptomatic and asymptomatic pseudarthrosis for re-
vision surgery, as CT defines the consolidation status and PET
pinpoints the ‘stress reaction’ at the vertebral endplates which
significantly correlates with Oswestry Disability Index score.
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Introduction
Low back pain (LBP) is a major global health and economic
problem [1], with a 1-year prevalence ranging from 22 % to
65 % and life-time prevalence of up to 84 % [2]. The direct costs
in The Netherlands (15 million inhabitants), including patient
care, medical procedures and medication, were estimated to be
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474 million Euros in 2007. However, the yearly indirect costs
caused by absence from work and early retirement in
TheNetherlands aremuch larger, i.e. 3.1 billion euros in 2007 [3].
LBP is mainly caused by degenerative spinal disorders,
such as spondylolisthesis, degenerative scoliosis, degenera-
tive disc disease, and recurrent disc herniations [4, 5]. If con-
servative measures, such as intensive exercise therapy, pain
medication or brace immobilization fail, operative interven-
tion is considered. Spinal fusion is a surgical procedure that
aims to eliminate painful intervertebral motion by rigid fixa-
tion usingmetal implants and bone grafts, to create a definitive
bony fusion. One of the most used spinal fusion techniques is
posterior lumbar interbody fusion (PLIF) which is character-
ized by a posterior surgical approach. Although multiple im-
provements in the surgical technique have led to higher fusion
rates, failed back surgery syndrome remains a substantial
problem [6]. Pseudarthrosis is defined as the absence of solid
bony fusion 1 year after the operation, and occurs in at least
15 % of primary lumbar fusions [7, 8]. Pseudarthrosis is typ-
ically associated with LBP or radicular pain as a result of
continued motion [6, 7]. However, pseudarthrosis may also
be asymptomatic or symptomsmay be atypical in a significant
proportion of patients. Persistent or recurrent pain is one of the
most important determinants in the decision to perform spinal
revision surgery [9]. Therefore, it is essential to objectively
relate pain symptoms to the degree of pseudarthrosis in order
to justify revision surgery of the vertebral segments [10].
Surgical exploration is currently the gold standard for the
detection of pseudarthrosis, but is highly invasive and recom-
mended only in patients with a high suspicion of pseudarthrosis
or hardware failure [6, 7, 11–13]. CT is a powerful imaging
modality that allows the detection of well-established bony
bridges between vertebrae. However, CT is of limited value
for the diagnosis of an evolving early-stage pseudarthrosis in
patients with symptoms early after surgery. Carreon et al. com-
pared CT data with revision surgical findings in 163 patients
with posterolateral fusion, and found that the diagnosis of bilat-
eral fusion as determined using thin-slice CT was confirmed
upon exploration in 96 % of the patients, indicating a high
negative predictive value for pseudarthrosis. However, the ab-
sence of fusion on one or both sides on CTwas a poor predictor
of pseudarthrosis upon surgical exploration (low positive pre-
dictive value) [12]. Moreover, the association between CT find-
ings and clinical symptoms is moderate [7, 14]. Nuclear bone
scanning may provide earlier functional diagnosis, and can be
performed using 99mTc-labelled diphosphonates, suitable for
SPECT/CT, or 18F-fluoride PET. Both tracers have similar up-
take mechanisms in newly formed bone or osteoid and are
therefore indicators of osteoblastic activity. However, 18F-fluo-
ride PET/CT may provide images with higher resolution and
sensitivity and better quantitation capabilities than 99mTc
SPECT/CT, that are necessary for evaluation of stress reactions
and bone remodelling processes in the spine.
The hypothesis of this study was that 18F-fluoride PET
could play a role in objectively relating clinical symptoms to
pseudarthrosis, as radiopharmaceutical activity functionally
correlates best with disease activity. Therefore, 18F-fluoride
PET may help discriminate between symptomatic and asymp-
tomatic pseudarthrosis and serve as an indicator for revision
surgery. To this end, we investigated the relationship between
18F-fluoride PET/CT and clinical symptoms after PLIF, not
only in patients with persistent or recurrent back pain, but also
in patients with minor or no pain.
Materials and methods
Patients
A total of 36 patients who had undergone PLIF were retro-
spectively included in the present analysis between June 2008
and October 2014. Of these patients, 18 suffered from persis-
tent or recurrent LBP without an apparent cause on conven-
tional scans and diagnostics (‘persistent pain’ group) at a var-
iable time-point after operation (range 9 to 76 months, mean
24.9 months, median 23 months). The other 18 patients were
recruited as a consecutive cohort during routine clinical and
radiological (plain radiography and CT) investigation 1 year
after PLIF (‘postoperative’ group; range 11 to 14 months,
mean 12.4 months, median 12 months). Three patients had
undergone PLIF surgery at two levels. Therefore, the total
number of operated levels to be analysed was 39. Operated
levels were L3–L4 (n=3), L4–L5 (n=15) and L5–S1 (n=21).
In part, this is an extension of a previous pilot study already
published [15].
Posterior lumbar interbody fusion: surgical technique
Under general anaesthesia and in a prone position, the verte-
bral arches of the intended levels were identified under fluo-
roscopic control and exposed using an open posterior lumbar
approach. Nerve roots were decompressed by laminectomy
and the intervertebral disc was excised. After thorough abra-
sion of the endplates, two 10 – 12-mm intervertebral cages
(Capstone® PEEK; Medtronic, Memphis, TN), were filled
with autologous bone from the vertebral lamina and inserted
into the disc space. The remaining disc space was packed with
additional autologous bone chips from the removed lamina.
Next, the upper and lower vertebrae were fixed using four
transpedicular screws connected to titanium rods (CD Lega-
cy®; Medtronic) for primary stabilization.
18F-Fluoride PET/CT scan acquisition
Sixty minutes after intravenous injection of 156 – 263 MBq
(mean 199MBq, median 196MBq) 18F-fluoride, PETand CT
1892 Eur J Nucl Med Mol Imaging (2015) 42:1891–1898
images were acquired with an integrated PET/CT scanner
(Gemini TF PET/CT; Philips, The Netherlands). After a
low-dose CT acquisition (120 kV, 30 mAs, slice thickness
4 mm) for attenuation correction, a PET scan was performed
in three-dimensional mode, acquiring two 5-min bed positions
covering the lumbosacral spine. This was immediately follow-
ed by a diagnostic CTscan without contrast enhancement (64-
slice helical, 120 kV, 250 mAs, slice thickness 1 mm with
increment of 0.8 mm) of the fusion region. Standard filtered
back projection CT reconstruction was performed. PET image
reconstruction included both non-attenuated and CT-based at-
tenuated data, using time-of-flight technology. Images were
viewed and postprocessed using clinical software (EBW;
Philips, the Netherlands), and further analysed using dedicat-
ed research software (PMOD 3.0, PMOD Technologies Ltd,
Zürich).
18F-Fluoride PET/CT data analysis
The 18F-fluoride PET/CT scans were evaluated by two inde-
pendent blinded observers (M.P., B.B.) who determined a vol-
ume of interest (VOI) for 18F-fluoride uptake calculation and
scored bony bridging based on the standard diagnostic CT
scans. Afterwards, discrepancies between the observers were
resolved by consensus. Scoring was verified by an orthopae-
dic surgeon (P.W.) and a musculoskeletal radiologist (R.W.).
Interbody fusion between the upper and lower vertebrae was
classified on the diagnostic CT scan as: the presence of a bony
bridge (Fig. 1) on both sides either within or around the cages
(score 2); the presence of a bony bridge on one side within or
around a cage, right or left (score 1); or no bridging (score 0).
Examples of these fusion scores are shown in Fig. 2. On each
low-dose CT scan, three ellipsoid VOIs were manually drawn
following the contours of the vertebrae (slice thickness 4 mm,
short axis range 40 – 50 mm, long axis range 55 – 65 mm),
including the intervertebral disc space and upper and lower
endplates of the segment operated upon (Fig. 3a). These VOIs
were then transferred to the coregistered attenuation-corrected
PET image (Fig. 3b), and in each of these VOIs, the SUVmax
was determined, i.e. activity in the upper, lower endplates and
the intervertebral disc space (SUVmaxU, SUVmaxL and
SUVmaxD, respectively), as well as the ratios of the upper
and lower endplate activities to the intervertebral disc space
activity (SUVratioU and SUVratioL, respectively).
Patient-reported outcome measures
Clinical wellbeing of the patients was evaluated using a set of
validated questionnaires:
1. The Oswestry Disability Index (ODI) is the most common-
ly used outcome measure for LBP and disability [16], and
assesses ten general daily tasks in relation to back-related
function, each with six possible answers [17].
2. Pain in the back and/or legs is reliably quantified using a
visual analogue scale (VAS) [9]. Patients were asked to
express the amount of pain in their back, right leg and left
leg separately on three scales ranging from 0 (no pain) to
100 (worst pain).
3. The EuroQol-5D (EQ-5D) is the most commonly used
instrument for measuring health-related quality of life in
The Netherlands [18]. The questionnaire consists of five
questions each with three possible answers, each question
representing a domain (i.e. mobility, self-care, usual ac-
tivities, pain/discomfort and anxiety/depression). The
EQ-5D index score was calculated based on a Dutch value
set, representative of the Dutch population with regard to
age and gender.
To facilitate further analysis of the data, each questionnaire
score was linearly rescaled on a scale of 0 to 100, with 0 the
worst possible score and 100 the best possible score. Patients
were divided into categories based on their questionnaire
score: patients with scores 0 – 40 were placed in category 1
(worst category), scores 40 – 60 in category 2 (intermediate
category), and scores 60 – 100 in category 3 (best category).
Statistical analysis
Statistical evaluation was performed using IBM SPSS Statis-
tics for Windows, version 20.0 (IBM Corporation, Armonk,
NY). To test the data for normality of distribution, the
Shapiro-Wilk test was used. If data were normally distributed,
an independent t test was used to test whether two samples
originated from the same distribution. If data were not
Fig. 1 Intervertebral bony fusion. Example of a bony bridge between the
cage and the lower vertebra (closed arrow), but not between the cage and
the upper vertebra (dotted arrow)
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normally distributed, the Mann-Whitney U test was used. P
values smaller than or equal to 0.05 were considered to indi-
cate statistically significant differences.
Results
Table 1 shows the distribution of SUV, CT and questionnaire
scores. As can be seen, a full range of symptomatic patients as
well as asymptomatic patients were included. As expected,
patients who presented during follow-up with persistent back
pain showed worse questionnaire scores than patients routine-
ly scanned postoperatively. For example, regarding back-
related function (ODI), 67 % of patients in the persistent pain
group fell into the intermediate or worst symptom category 1
or 2, while only 11 % in the postoperative group were in these
categories. Importantly, there was also high similarity between
the questionnaire scores: a low or high ODI score consistently
corresponded to a low or high VAS score and a low or high
EQ-5D score, with R values of 0.9, 0.7 and 0.6 between ODI
and VAS, ODI and EQ-5D and VAS and EQ-5D, respectively.
Fig. 4 shows the relationship between the intervertebral fu-
sion score on CT and the ODI scores. ODI scores were 53.1±
25.3 for fusion score 0, 78.6±18.0 for score 1, and 66.0±25.4
for score 2 (mean±standard deviation). Only the difference in
ODI score between fusion score 0 and 1 was statistically signif-
icant (p=0.017; p=0.226 between scores 0 and 2, and p=0.163
between scores 1 and 2). Therefore, no consistent correlation
could be observed between pain severity and CT fusion score.
For VAS and EQ-5D similar statistically significant results were
obtained, with only statistically significant differences between
groups 0 and 1 (p=0.03 for both VAS and EQ-5D).
Regarding PET scan values, Fig. 5 shows the relationship
between the ODI category and PET endplate SUVmax. Upper
endplate SUVmaxU values were 18.1±3.8 for ODI category 1,
13.2±1.9 for category 2, and 13.7±3.6 for category 3. The
activity of the upper vertebral endplate in the entire study
population was significantly higher in patients with the lowest
ODI category (with the worst clinical performance) than in
those with other ODI categories (p=0.02 between ODI cate-
gories 1 and 2, p=0.01 between 1 and 3, and p=0.7 between 2
and 3). Lower endplate SUVmaxL values were 17.1±5.9 for
ODI category 1, 13.5±2.1 for category 2, and 13.7±3.6 for
category 3. For the lower endplate, similar statistically signif-
icant results were found (p=0.04 between ODI categories 1
and 2, p=0.05 between 1 and 3, and p=0.9 between 2 and 3).
Intervertebral disc space SUVmaxD values were 16.8±5.0 for
ODI category 1, 13.6±2.2 for category 2, and 12.3±3.2 for
category 3; there were no statistically significant differences
between categories (p=0.06 between ODI categories 1 and 2,
p=0.22 between 1 and 3, and p=0.16 between 2 and 3). For
VAS and EQ-5D, the results were less clear, with only
SUVmaxU scores being significantly different between catego-
ries 1 and 2 (p=0.04).
Fig. 2 Examples of CT fusion
scores 0 (a), 1 (b) and 2 (c)
Fig. 3 18F-Fluoride PET analysis
of the segment operated upon.
Coronal CT and PET images of
the lumbar spine after posterior
lumbar interbody fusion, in which
three VOIs were drawn in the
segment operated upon: the lower
endplate of the cranial vertebra
(blue), the intervertebral disc
space (pink) and the upper
endplate of the caudal vertebra
(black)
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SUVratioU was 1.2±0.5 for ODI category 1, 1.0±0.2 for
category 2, and 1.2±0.4 for category 3; there were no statisti-
cally significant differences between categories. For
SUVratioL, similar statistically significant results were found.
For VAS and EQ-5D similar statistically significant results
were also found. Thus, inclusion of the activity of the inter-
vertebral fusion area in the PET endplate activity calculation
did not result in a better correlation with symptoms.
Fig. 6 shows the relationship between 18F-fluoride ac-
tivity on PET (i.e. SUVratioU and SUVratioL) and CT fu-
sion scores. There were a significant correlation, with
SUVratioU values of 1.4±0.4 for fusion score 0, 1.2±0.3
for fusion score 1, and 1.0±0.2 for fusion score 3 (p=0.04
between scores 0 and 1, p=0.003 between scores 0 and 2,
p=0.09 between scores 1 and 2). For the lower endplate
similar statistically significant results were found.
SUVratioU values were 1.5±0.6 for fusion score 0, 1.1±
0.3 for fusion score 1 and 1.0±0.3 for fusion score 3 (p=
0.05 between scores 0 and 1, p=0.003 between scores 0
and 2, p=0.29 between scores 1 and 2). Interestingly, the
PET activity ratio in patients with fusion score 1 was not
significantly lower than in patients with fusion score 2.
Table 1 Key findings
Persistent pain group (n=18) Postoperative group (n=18)
Interval primary PLIF surgery – PET/CT (months), mean (range) 24.9 (9 – 76) 12.4 (11 – 14)
Imaging findings
PET, mean (standard deviation)
SUVmax upper endplate 14.3 (4.4) 14.9 (3.9)
SUVmax intervertebral disc 12.5 (4.5) 15.0 (6.5)
SUVmax lower endplate 14.3 (5.3) 14.0 (3.6)
SUVratio upper endplate 1.2 (0.4) 1.0 (0.3)
SUVratio lower endplate 1.2 (0.5) 1.0 (0.3)




Clinical findings, mean (standard deviation)
ODI 49.9 (22.6) 82.6 (12.5)
VAS 50.7 (23.6) 81.2 (16.2)
EQ-5D 62.0 (23.8) 83.4 (14.0)
a Number of levels
Fig. 4 Relationship between fusion on CT (score 0, 1 or 2) and ODI
score (0 – 100). Only the difference between CT scores 0 and 1 was
statistically significant (*p<0.05)
Fig. 5 Relationship between ODI categories and SUVmax endplate
activity on PET. SUVmaxU was significantly higher in patients in ODI
category 1 (the worst clinical performance), as compared to the other
categories (*p<0.05, **p<0.01)
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Discussion
This is the first study using 18F-fluoride PET/CT to evaluate
symptomatic as well as asymptomatic patients after spinal
interbody fusion surgery and to correlate the PET and CT
findings with patient-reported functionality after the surgical
procedure. Pain is often multifactorial in these patients and not
always alleviated by surgery. Importantly, psychosocial fac-
tors can result in a refractory state, especially after many years
of debilitating pain [7]. To minimize the impact of such con-
founding factors, patients were surveyed using multiple pa-
tient questionnaires simultaneously. While ODI is a specific
questionnaire relating to LBP and physical limitation in daily
life, VAS evaluates only subjective pain intensity, and EQ-5D
relates to general health status and psychological wellbeing.
The scores for the three questionnaires were similar indicating
that that pain, functional capacity and psychological wellbeing
are affected in all patients in an integrated manner. As pain is a
leading determinant in the decision to perform surgery, corre-
lation between imaging findings and objective clinical param-
eters as assessed by validated and specific patient-reported
outcome measures is vital.
Several studies have explored the use of 18F-fluoride PET
and CT in patients with persistent pain after a spinal fusion
procedure. Gamie and El-Maghraby [19] studied a group of
67 patients, including 25 after surgery, with back pain and
negative conventional imaging, and found positive areas of
uptake in facet joints and/or discs in 8 of 8 patients (100 %)
who had undergone lumbar fusion. Fischer et al. [20] studied a
group of 20 patients with persistent pain after cervical or lum-
bar fusion. They showed that even 10 years after surgery, there
was increased tracer uptake around 8 of 17 cages in the inter-
vertebral disc space, suggesting increased stress or
microinstability and absence or incomplete osseous fusion.
PET imaging supported the diagnosis of non-union or con-
firmed the diagnosis of complete fusion. Quon et al. [21] per-
formed a prospective study in a cohort of 116 patients. In 52 of
these patients (45 %) clinical evaluation and CT did not con-
clusively indicate the appropriate management and therefore
these patients underwent PET/CT. Ultimately, 15 patients
underwent revision surgery on the basis of abnormal 18F-fluo-
ride foci at various sites, i.e. cages, grafts, screws, rods and
fixation hardware. PET/CTcorrectly predicted the presence of
an abnormality (cage failure, screw loosening, graft fracture)
requiring surgical intervention in 14 of the 15 patients. Thus,
PET/CT correctly identified patients requiring surgical man-
agement. Byrnes et al. [22] recently reported clinically useful
18F-fluoride PET/CT findings in 49 of 58 patients (85 %) with
neck pain after cervical fusion. While these studies indicate
the value of 18F-fluoride PET in a subset of symptomatic pa-
tients, they did not include paucisymptomatic or asymptom-
atic patients. In view of the low specificity of symptomatology
and high sensitivity of PETwhich carries the risk of a substan-
tial number of false-positive findings that is undesirable for
s u r g i c a l man ag emen t , w e t h i n k i n c l u s i o n o f
paucisymptomatic or asymptomatic patients is crucial for the
implementation of this technique.
PET activity at the vertebral endplates (SUVmaxU and
SUVmaxL), but not within the intervertebral disc space
(SUVmaxD, SUVratioU and SUVratioL), was correlated with
the specific LBP and disability symptoms as measured using
ODI score. We have previously found [15] that increased trac-
er uptake in the vertebral endplates is correlated with the oc-
currence and magnitude of subsidence in this type of patient,
indicating instability with vertebral collapse of endplates. Sub-
sidence is defined as sinking of a fusion cage into one or both
of the adjacent vertebral bodies [23]. However, the clinical
relevance of subsidence remains a matter of debate since the
magnitude of subsidence does not match the final clinical
results [24]. Fischer et al. [20] have also interpreted persistent
increased uptake above and below the cage as inactive or
unsuccessful fusion due to increase stress and microinstability.
We were not able to demonstrate a consistent correlation be-
tween ODI score and CT fusion score: while significantly
different ODI scores were found between CT fusion scores 0
and 1, this was paradoxically not the case between CT fusion
scores 0 and 2. This could have been related to the wide range
of ODI scores associated with CT fusion score 2, which may
have been due to other causes of pain sensation in these pa-
tients. There appears to be an inverse correlation between the
Fig. 6 Relationship between CT
fusion scores and SUVmax ratios.
SUVratioU and SUVratioL in
patients with pseudarthrosis (CT
fusion score 0) were significantly
higher than in patients with score
1 or 2 (*p<0.05, **p<0.01)
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CT fusion score and SUVratio (ratio between the endplate SUV
and the intervertebral disc space SUV).
In a normally evolving fusion the number of intervertebral
bridges increases from CT fusion score 0 to 1 to 2 over time,
while PET activity develops from highly active endplates
combined with a relatively silent intervertebral disc space
(SUVratio >1.0) to an even activity distribution over the two
areas (SUVratio about 1.0). This is evidence for the hypothesis
that the existence of bony bridges (one or two) in combination
with ‘absence’ of PET uptake indicates a stable fusion (ab-
sence of pseudarthrosis), and in the case of pseudarthrosis (no
detectable bony bridges on CT), PET uptake pinpoints the
symptomatic pseudarthrosis. Uptake at the endplates probably
reflects ongoing stress reactions, due to an unstable lumbar
fusion.
This study was limited by a lack of correlation to the gold
standard of surgical exploration.We found no previous studies
on the PLIF procedure that investigated the correlation be-
tween the surrogate gold standard high-resolution CT findings
and surgical exploration. In posterolateral fusion, CT had a
very low positive predictive value, indicating that complete
mineralization of bony bridges may take substantially longer
to show on CT. Prospective studies are needed that will ad-
dress this in conjunction with PET findings. At our institution,
implant removal is not standard practice and revision surgery
is only performed in a highly selected group of pseudarthrosis
patients with substantial pain. Clinical follow-up can also be
used as a surrogate gold standard, but a considerable number
of patients and time intervals as well as repeated PET/CT
scans would be needed to fully account for all influencing
confounding factors and coexisting abnormalities. Therefore,
the potential of the PET scan to predict therapy management
could not be fully assessed in this study. However, the main
goal of this study was to evaluate the relationship between
active PET scan abnormalities and symptoms. Furthermore,
large differences between patients in the time between fusion
surgery and 18F-fluoride PET/CTexamination were present. A
similar follow-up period for all patients would have been ide-
al, but was not feasible within the limits of clinical practice,
because symptomatic patients can present with pain at any
time from months to years after PLIF. For asymptomatic pa-
tients, it is not feasible to perform PET/CT many months to
years after a successful fusion procedure. Finally, another lim-
itation of the study was the small sample size.
In conclusion, our study demonstrated that 18F-fluoride up-
take on PETcorrelates better with symptomatic pseudarthrosis
than the CT findings. Furthermore, an inversed relationship
between PET uptake and CT score was found.
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